KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) Earnings History
Annual and quarterly earnings data from 2020 to 2025
Loading earnings history...
KMTS EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
KMTS Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 40.5% | -177.8% | -190.3% |
| 2024 | 1.3% | -305.8% | -338.4% |
| 2023 | -139.6% | -1054.0% | -1104.0% |
| 2021 | - | - | - |
| 2020 | - | - | - |
Download Data
Export KMTS earnings history in CSV or JSON format
Free sign-in required to download data
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) Earnings Overview
As of May 8, 2026, KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) reported trailing twelve-month net income of -$145M, reflecting -151.5% year-over-year growth. The company earned $-2.74 per diluted share over the past four quarters, with a net profit margin of -190.3%.
Looking at the long-term picture, KMTS's historical earnings data spans multiple years. The company achieved its highest annual net income of -$29M in fiscal 2020.
KESTRA MEDICAL TECHNOLOGIES, LTD. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including MDT ($4.61B net income, 13.9% margin), ABT ($13.98B net income, 31.9% margin), BSX ($2.89B net income, 14.4% margin), KMTS has room to improve margins relative to the peer group. Compare KMTS vs MDT →
KMTS Earnings vs Peers
Earnings metrics vs comparable public companies
KMTS Historical Earnings Data (2020–2025)
5 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$114M | -20.9% | -$106M | $-5.13 | -190.3% | -177.8% |
| 2024 | -$94M | -11.7% | -$85M | $-2.04 | -338.4% | -305.8% |
| 2023 | -$84M | -147.0% | -$80M | $-1.75 | -1104.0% | -1054.0% |
| 2021 | -$34M | -15.7% | -$33M | $-0.69 | - | - |
| 2020 | -$29M | - | -$29M | $-0.59 | - | - |
See KMTS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs KMTS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare KMTS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonKMTS — Frequently Asked Questions
Quick answers to the most common questions about buying KMTS stock.
Is KMTS growing earnings?
KMTS EPS fell to $-2.74, with earnings declining -151.5%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-145M.
What are KMTS's profit margins?
KESTRA MEDICAL TECHNOLOGIES, LTD. net margin is -190.3%, with operating margin at -177.8%. Below-average margins reflect competitive or cost pressures.
How consistent are KMTS's earnings?
KMTS earnings data spans 2020-2025. The declining earnings trend is -151.5% YoY. Historical data enables comparison across business cycles.